Supported in Our Commitment to Health Equity

At CareMessage, we are committed to transforming healthcare for underserved populations by leveraging innovative technology to address barriers to care. Through our General R&D Fund, we aim to further our mission of impacting the lives of 5 million people from low-income communities annually by 2028. With a proven track record of reaching over 20 million patients, exchanging 500 million messages, and supporting 460 safety-net healthcare organizations, our R&D initiatives focus on driving health equity in the areas of Access to Care, Clinical Outcomes, and Social Determinants of Health.

The General R&D Fund fuels research and development of innovative projects that are on the scale of weeks to months, rather than multiple years. Projects such as deepening integrations with electronic health records (EHRs) to automate care gap closures in areas like cervical and colorectal cancer screenings, and expanding our patented messaging workflow builder to empower customers with self-serve tools. In 2025 we are also planning on developing new patient segmentation methods to deliver targeted interventions, researching care access workflows for Medicaid enrollment and redetermination, and conducting expanded clinical market research to ensure our solutions remain market-leading. These efforts will reduce the administrative burden on clinical staff while improving outcomes for patients, ensuring that care is both scalable and equitable.

Your support of the CareMessage General R&D Fund allows us to continue pioneering new solutions for underserved communities, ensuring every patient has access to timely, impactful care. Together, we can develop technologies that improve health equity, enhance clinical workflows, and create lasting change for the millions of individuals who rely on safety-net healthcare systems. Join us in building a healthier, more accessible future for all.